Gene550
AUP1: AUP1 lipid droplet regulating VLDL assembly factor
Cite this record
ConductScience Library. AUP1: AUP1 lipid droplet regulating VLDL assembly factor. Genes, record 550. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/550
- Sources
- 13 sources
- Release
- gene-search-2026-11-13-0.2.1
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9Y679 | Lipid droplet-regulating VLDL assembly factor AUP1 | 410 | 2 | Ensembl, GeneID, HGNC |
Source UniProt
Patents61
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 20260139247 A1 | 2026-05-21 | 547 | Q9Y679 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 37370 | Q9Y679 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 9929 | Q9Y679 | Espacenet |
| US 20250320254 A1 | 2025-10-16 | 9929 | Q9Y679 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 547 | Q9Y679 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 547 | Q9Y679 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 547 | Q9Y679 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 9929 | Q9Y679 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 4699 | Q9Y679 | Espacenet |
| US 20240398993 A1 | 2024-12-05 | 11049 | Q9Y679 | Espacenet |
NIH grants272
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | AUP1 papers | Newest fiscal year |
|---|---|---|---|
| R01AG011085 | Ubiquitin‐mediated proteolysis and cell cycle control | 3 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 2 | 2025 |
| R35GM133552 | Coordination of chaperone interactions that dictate protein folding and trafficking | 2 | 2025 |
| I01BX003415 | Harnessing the Autophagy-Lysosomal Biogenesis Response in Macrophages to Treat Atherosclerosis | 1 | 2025 |
| K12CA087723 | Dana Farber/Harvard Cancer Consortium Career Development Program in Clinical Oncology | 1 | 2025 |
| P01AI138949 | Ixodes scapularis Immuno-Developmental and Metabolic Signaling Pathways and Interference with Ticks and Tick-borne Pathogens | 1 | 2025 |
| P20GM103418 | Kansas IDeA Network of Biomedical Research Excellence 5 | 1 | 2025 |
| P30CA013330 | Cancer Center Support Grant | 1 | 2025 |
| P30CA015704 | Cancer Center Support Grant | 1 | 2025 |
| P30CA030199 | Cancer Center Support Grant (CCSG) | 1 | 2025 |
Source NIH's project files
Papers323
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Novel Role of the Ubiquitin Conjugating Enzyme, UBE2G2, in Regulation of Cell Shape and Movement. | FASEB J | 2026 | 41989348 | PubTator, text mining | PubMed |
| Integrated machine learning and single-cell analysis reveal the prognostic and therapeutic potential of SUMOylation-related genes in ovarian cancer. | Front Immunol | 2025 | 40534859 | PubTator, text mining | PubMed |
| AUP1 and UBE2G2 complex targets STING signaling and regulates virus-induced innate immunity. | mBio | 2025 | 40237449 | PubTator, text mining | PubMed |
| Increased Immune Infiltration and Improved Prognosis of Head and Neck Squamous Cell Carcinoma Associated with Reduced Ancient Ubiquitous Protein 1 Gene Expression. | Mol Biotechnol | 2025 | 38862860 | PubTator, text mining | PubMed |
| AUP1 transcriptionally activated by KDM5B reprograms lipid metabolism to promote the malignant progression of cervical cancer. | Int J Oncol | 2024 | 39329209 | PubTator, text mining | PubMed |
| Screening of genes related to programmed cell death in esophageal squamous cell carcinoma and construction of prognostic model based on transcriptome analysis. | Expert Rev Anticancer Ther | 2024 | 38975629 | PubTator, text mining | PubMed |
| Identification and Analysis of Biomarkers Associated with Lipophagy and Therapeutic Agents for COVID-19. | Viruses | 2024 | 38932215 | PubTator, text mining | PubMed |
| Glycometabolism and lipid metabolism related genes predict the prognosis of endometrial carcinoma and their effects on tumor cells. | BMC Cancer | 2024 | 38720279 | PubTator, text mining | PubMed |
| Correction: The pyruvate dehydrogenase complex regulates mitophagic trafficking and protein phosphorylation. | Life Sci Alliance | 2024 | 38485152 | PubTator, text mining | PubMed |
| AUP1 Regulates the Endoplasmic Reticulum-Associated Degradation and Polyubiquitination of NKCC2. | Cells | 2024 | 38474353 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/550
GET https://conductscience.org/api/genes/v1/550/patents?page=2